Personalis Inc (PSNL) Stock Price, Quote & News

Company Profile

Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome sequencing data with advanced analytics to provide a multi-dimensional view of the tumor an...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 650 752 1300

Fax: 650 752 1301

Website: www.personalis.com

Address:

6600 Dumbarton Circle, Fremont, United States

Bulltrader988 Aug. 23 at 8:17 PM

$PSNL 👃👀 https://prismmarketview.com/personalis-secures-13-5m-on-va-task-order-extending-role-in-national-genomic-initiative/

0 · Reply

Farorm Aug. 22 at 8:14 PM

$PSNL we closed below, surprise.

1 · Reply

lucianw Aug. 22 at 7:53 PM

$PSNL Absolutely pathetic performance today given the market is going wild and how we just got new VA orders. Unbelievable we are still stuck in 4s when the first reimbursement is expected in the coming month.

1 · Reply

arribaStocktrading Aug. 22 at 7:15 PM

$PSNL Green Day isn't just a band:

0 · Reply

Bulltrader988 Aug. 22 at 6:52 PM

$PSNL 8k filled today: "...On August 19, 2025, Personalis, Inc. received a new task order under its contract with the U.S. Department of Veterans Affairs (VA) for the VA's Million Veteran Program (VA MVP). The new task order is effective on September 30, 2025 and has a value of up to $13.5 million, subject to the receipt of samples from the VA MVP and performance of services by Personalis. The cumulative value of task orders received by Personalis under its contracts with the VA MVP has increased to approximately $225.0 million..." 👃👀 https://www.sec.gov/ix?doc=/Archives/edgar/data/1527753/000095017025110739/psnl-20250819.htm

0 · Reply

Bulltrader988 Aug. 22 at 6:14 PM

$PSNL in play? 👃👀

0 · Reply

Farorm Aug. 22 at 6:04 PM

$PSNL closing above sma200? I guess no.

0 · Reply

Skibum77 Aug. 22 at 3:58 PM

$PSNL name that chart pattern😎

2 · Reply

E444 Aug. 22 at 2:11 PM

$PSNL had me in the first 30min something is up higher we go

0 · Reply

prismmarketview Aug. 22 at 1:38 PM

(NASDAQ: $PSNL) @PersonalisInc secured a new VA task order worth up to $13.5M under the Million Veteran Program, set to begin Sept. 30, 2025. With nearly $225M in cumulative awards, the partnership underscores Personalis’ vital role in large-scale genomics and precision medicine. https://prismmarketview.com/personalis-secures-13-5m-on-va-task-order-extending-role-in-national-genomic-initiative/

0 · Reply

Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

SMCI

Aug 5, 2025, 10:49 PM EDT - 19 days ago

Personalis, Inc. (PSNL) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:01 PM EDT - 19 days ago

Personalis Reports Second Quarter 2025 Financial Results

Jul 22, 2025, 4:01 PM EDT - 4 weeks ago

Personalis to Announce Second Quarter 2025 Financial Results

Jul 18, 2025, 4:00 PM EDT - 5 weeks ago

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jul 9, 2025, 4:00 PM EDT - 6 weeks ago

Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients

TEM

Jun 3, 2025, 4:00 PM EDT - 2 months ago

Personalis' NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO

Jun 2, 2025, 4:00 PM EDT - 2 months ago

New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse

May 22, 2025, 6:00 AM EDT - 3 months ago

Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection

May 14, 2025, 4:01 PM EDT - 3 months ago

Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference

May 6, 2025, 8:41 PM EDT - 3 months ago

Personalis, Inc. (PSNL) Q1 2025 Earnings Call Transcript

May 6, 2025, 4:01 PM EDT - 3 months ago

Personalis Reports First Quarter 2025 Financial Results

Apr 28, 2025, 5:00 PM EDT - 4 months ago

Personalis' NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study

Apr 22, 2025, 4:01 PM EDT - 4 months ago

Personalis to Announce First Quarter 2025 Financial Results

Apr 22, 2025, 6:00 AM EDT - 4 months ago

Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection

Mar 26, 2025, 4:01 PM EDT - 5 months ago

Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference

Mar 3, 2025, 6:00 AM EST - 6 months ago

New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection

Feb 27, 2025, 7:40 PM EST - 6 months ago

Personalis, Inc. (PSNL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:01 PM EST - 6 months ago

Personalis Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 21, 2025, 4:21 PM EST - 6 months ago

3 Biotech/Healthcare Names Under $10 I Am Buying Now

ARDX GERN MRNA TEM

Feb 18, 2025, 4:01 PM EST - 6 months ago

Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference

Feb 14, 2025, 10:50 AM EST - 6 months ago

Exciting Technology At Personalis, But Profitability Eludes Them

Feb 13, 2025, 4:01 PM EST - 6 months ago

Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results

Jan 28, 2025, 4:01 PM EST - 7 months ago

Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Jan 13, 2025, 5:00 AM EST - 8 months ago

New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer

Jan 7, 2025, 4:01 PM EST - 8 months ago

Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue

Dec 19, 2024, 9:00 AM EST - 8 months ago

Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna

Dec 16, 2024, 8:00 AM EST - 8 months ago

Personalis and Tempus Expand Collaboration to Biopharma

TEM

Nov 20, 2024, 4:01 PM EST - 9 months ago

Personalis to Participate at Upcoming Investor Conferences

Nov 6, 2024, 8:11 PM EST - 10 months ago

Personalis, Inc. (PSNL) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:01 PM EST - 10 months ago

Personalis Reports Third Quarter 2024 Financial Results

Nov 5, 2024, 4:01 PM EST - 10 months ago

Personalis to Present at the Stifel 2024 Healthcare Conference

Oct 23, 2024, 4:01 PM EDT - 10 months ago

Personalis to Announce Third Quarter 2024 Financial Results

Sep 16, 2024, 9:00 AM EDT - 1 year ago

ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test

Aug 18, 2024, 7:47 AM EDT - 1 year ago

Personalis: Resetting My Strategy Following The Q2 Beat

Aug 16, 2024, 8:30 AM EDT - 1 year ago

Personalis and Tempus Announce Expanded Collaboration

TEM

Aug 7, 2024, 11:09 PM EDT - 1 year ago

Personalis, Inc. (PSNL) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:01 PM EDT - 1 year ago

Personalis Reports Second Quarter 2024 Financial Results

Jul 31, 2024, 4:01 PM EDT - 1 year ago

Personalis to Participate at the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Jul 24, 2024, 4:01 PM EDT - 1 year ago

Personalis to Announce Second Quarter 2024 Financial Results

Jun 18, 2024, 4:01 PM EDT - 1 year ago

Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference

Jun 13, 2024, 8:00 AM EDT - 1 year ago

Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call

Jun 4, 2024, 4:05 PM EDT - 1 year ago

ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring

May 31, 2024, 9:05 AM EDT - 1 year ago

Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus

May 22, 2024, 9:05 AM EDT - 1 year ago

Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024

May 22, 2024, 9:00 AM EDT - 1 year ago

Antares Bolsters Private Wealth Team with Three New Senior Appointments

KHC

May 8, 2024, 11:53 PM EDT - 1 year ago

Personalis, Inc. (PSNL) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:01 PM EDT - 1 year ago

Personalis Reports First Quarter 2024 Financial Results

Apr 24, 2024, 4:01 PM EDT - 1 year ago

Personalis to Announce First Quarter 2024 Financial Results

Mar 28, 2024, 4:01 PM EDT - 1 year ago

Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference

Bulltrader988 Aug. 23 at 8:17 PM

$PSNL 👃👀 https://prismmarketview.com/personalis-secures-13-5m-on-va-task-order-extending-role-in-national-genomic-initiative/

0 · Reply

Farorm Aug. 22 at 8:14 PM

$PSNL we closed below, surprise.

1 · Reply

lucianw Aug. 22 at 7:53 PM

1 · Reply

arribaStocktrading Aug. 22 at 7:15 PM

$PSNL Green Day isn't just a band:

0 · Reply

Bulltrader988 Aug. 22 at 6:52 PM

0 · Reply

Bulltrader988 Aug. 22 at 6:14 PM

$PSNL in play? 👃👀

0 · Reply

Farorm Aug. 22 at 6:04 PM

$PSNL closing above sma200? I guess no.

0 · Reply

Skibum77 Aug. 22 at 3:58 PM

$PSNL name that chart pattern😎

2 · Reply

E444 Aug. 22 at 2:11 PM

$PSNL had me in the first 30min something is up higher we go

0 · Reply

prismmarketview Aug. 22 at 1:38 PM

0 · Reply

LordBrypto Aug. 22 at 12:29 PM

$PSNL

0 · Reply

Bulltrader988 Aug. 22 at 11:51 AM

$PSNL 👃👀 https://seekingalpha.com/news/4488258-personalis-stock-gains-va-work-order?utm_source=webull.com&utm_medium=referral&feed_item_type=news

0 · Reply

arribaStocktrading Aug. 22 at 11:42 AM

$PSNL Good to see the VA's MVP contract with Personalis go up in Dollar Value from the previous 2 years. If I'm not mistaken this will be year 3 of their 5-year contract extension and they had to fight for this extension too if you recall. There's competition in everything but Personalis can win. If you think about it, their slogan "Win In MRD" also acknowledges that a highly competitive landscape is anticipated. You can't win anything unless there's competition and hardly anything in the healthcare space is just outright gifted your way. Good on us.

2 · Reply

Farorm Aug. 22 at 10:51 AM

$PSNL https://investors.personalis.com/static-files/6f608b31-820f-4055-86f7-50a07f5d3d5c

1 · Reply

E444 Aug. 22 at 10:47 AM

$PSNL are we done with the shake out? Time to print some money?

0 · Reply

LordBrypto Aug. 22 at 12:57 AM

$PSNL woah after hours jump

0 · Reply

BioTechNoir Aug. 21 at 3:36 PM

$PSNL SLEEPY LIKE BULL

1 · Reply

LordBrypto Aug. 21 at 1:12 AM

$PSNL wen reimbursement

3 · Reply

BeeDecay Aug. 20 at 8:44 PM

$PSNL https://www.linkedin.com/posts/personalis-inc_ctdna-based-immunotherapy-monitoring-in-advanced-activity-7359252071822315521-yINY

0 · Reply

LordBrypto Aug. 20 at 4:52 PM

$PSNL

0 · Reply

arribaStocktrading Aug. 20 at 2:26 PM

$PSNL The NASDAQ is getting less expensive today and we're not... so at least there's that.

0 · Reply

magnitudeFC Aug. 20 at 12:05 AM

$PSNL Is there a forced seller? Kinda weird to be selling here so close to reimbursement

1 · Reply

Market Cap	428.31M
Revenue (ttm)	84.61M
Net Income (ttm)	-81.28M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-96.06%
Debt to Equity Ratio	0.00

Volume	1,300,100
Avg Vol	1,378,350
Day's Range	N/A - N/A
Shares Out	88.68M
Stochastic %K	66%
Beta	1.86
Analysts	Strong Sell
Price Target	$7.19